DMC Inhaler
for Anaphylaxis

At DMC we think differently about emergency drug delivery. Our first generation device treats anaphylaxis by delivering epinephrine through inhalation.

The technology utilises the pulmonary pathway to deliver life-saving medication. The large surface area of the lungs allows medications to be rapidly absorbed into the blood stream.

EMERGENCY SOLUTIONS FOR THE IMMEDIATE TREATMENT OF LIFE THREATENING CONDITIONS

The inhaler aims to improve upon the current standard of care by being:
  • Needle-free, removing any fear or hesitation
  • 8 times faster to reach Cmax than widely used auto injector*
  • Intuitive and easy to use
  • A convenient small sized device
  • Having a long expiry with convenient storage requirements

* In Phase 1 clinical studies testing inhalation delivery of DMC’s proprietary epinephrine formulation, plasma epinephrine concentrations reached Cmax 8 times faster compared to a widely used autoinjector.

“It is very surprising because I have never heard of something that could be inhaled that would aid in an anaphylactic reaction.“
FOCUS GROUP FEEDBACK
“It is very surprising because I have never heard of something that could be inhaled that would aid in an anaphylactic reaction.“
FOCUS GROUP FEEDBACK

Easy to Use

The DMC inhaler is exactly that – a device that delivers epinephrine via inhalation.

It’s as simple as taking the red cap off and inhaling. 

As there will be no reasons for hesitation, delivery will be earlier than when using injectors, particularly for first time users.

Learn more about our device

Contact Us